ReferIndia News Sudeep Pharma's Shares End With A 30.54% Premium Against The Issue Price Of ₹593

ReferIndia News

Dr. Aditya Manke

Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.

Contact Now
News Image

Sudeep Pharma's Shares End With A 30.54% Premium Against The Issue Price Of ₹593

Published on: Nov. 29, 2025, 10:10 a.m. | Source: Free Press Journal

Shares of Sudeep Pharma ended with a premium of 30.54 per cent against the issue price of Rs 593. Proceeds from the fresh issue to the tune of Rs 75.81 crore will be used for capital expenditure toward the procurement of machinery for its production line located at the Nandesari Facility 1, Gujarat, and for general corporate purposes.

Checkout more news
Ad Banner

वसई-विरार में बेहतरीन सर्जरी हॉस्पिटल की तलाश?

VHMC हॉस्पिटल — वसई-विरार में भरोसेमंद सर्जरी और आधुनिक इलाज का नाम, जहाँ मरीजों की सेहत हमारी पहली प्राथमिकता है।

संपर्क करें
ReferIndia News contact